Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
AMAG Pharmaceuticals Inc. (AMAG)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: AMAG
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on AMAG
Hedge Fund Portfolio Tracking: Galleon Group (Raj Rajaratnam), Q3 2008
[View article]
More info - http://actual-news-of-day.blogspot.com/
Comment by
michaelmettlen
Oct 16 13:54 pm
|
Rating:
0
0
Sequenom's Bombshell
[View article]
I like this company, despite the mishandling of data by employees. Even at current levels, $5.50, this stock has upside potential of $15...
More »
Comment by
allen_95677
Sep 26 20:13 pm
|
Rating:
0
0
Goldman Sachs Hedge Fund Trend Monitor
[View article]
I think the basic flaw in stock picking is that it is in reality a bet against the stock market - will "my" stock be better or worse...
More »
Comment by
AJ Clausen
Sep 6 04:26 am
|
Rating:
0
0
Goldman Sachs Hedge Fund Trend Monitor
[View article]
Bloggers and other advisors who cite strategies which have "beaten the market by 14% (or "2.8%") a year since 2001" do a disservice to...
More »
Comment by
bordo
Sep 5 10:57 am
|
Rating:
+2
-1
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
[View article]
how about the dcgn to keep??? i think this company has a good future.... how do you guys think of it?
Comment by
ngeng
Aug 12 21:26 pm
|
Rating:
0
0
AMAG Pharmaceuticals' Feraheme: The Next Billion Dollar Drug
[View article]
A quick comment on your analysis of the dialysis population. You cite staff time and visits as a driver for cost savings and, therefore,...
More »
Comment by
User 465720
Aug 3 20:12 pm
|
Rating:
0
0
Wednesday's Options Recap
[View article]
USU got shafted by the Obama administration, all things nuclear are bad don't you know. I am sure as soon as some of USU cash on hand...
More »
Comment by
carbonblack
Jul 28 09:17 am
|
Rating:
0
0
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
[View article]
Your assessment is off tract, Mr. Zeng. If it's too hot for you, get out of the kitchen. On Jun 03 04:33 AM PeteK wrote: >...
More »
Comment by
optimal90
Jul 11 23:08 pm
|
Rating:
0
0
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
[View article]
CTIC is next generation Biopharm company. It's making all the right moves. Look at how CTIC resists this market (up 20% one day and down...
More »
Comment by
optimal90
Jul 11 23:03 pm
|
Rating:
0
0
Expect FDA Approval of AMAG Pharmaceutical's Feraheme
[View article]
It seems the big boys sold on news down over 10% since FDA announcement with nearly 3 million shares traded on July 1st!!!!!
Comment by
User 444631
Jul 10 03:49 am
|
Rating:
0
0
FDA Calendar: 18 Hot Summer Trades
[View article]
Good list. So far, this has been one of the best years for FDA investing. Buying in advance of the date and selling before the decision...
More »
Comment by
adenovir
Jul 3 14:34 pm
|
Rating:
+1
0
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart
[View article]
Good point. It was a bad trade, no way around it. On Jul 01 12:14 PM biotechoptions wrote: > where's the hedge?!?
Comment by
The Inflection Point
Jul 1 21:05 pm
|
Rating:
0
0
Closing Update for Wednesday, July 1
[View article]
It terms of GSIG, it wasn't just about restating revenue today. It was about yesterday's news after the close regarding restructuring...
More »
Comment by
Tom Shohfi
Jul 1 20:01 pm
|
Rating:
+2
0
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart
[View article]
where's the hedge?!?
Comment by
biotechoptions
Jul 1 12:14 pm
|
Rating:
0
0
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
[View article]
I like APPY here although the full market potential will likely not be reached until the second half of 2010. The firm has developed the...
More »
Comment by
Dan Weiss
Jul 1 09:48 am
|
Rating:
0
0
1
2
3
4
5
6
7
Next Page
Hedge Fund Portfolio Tracking: Galleon Group (Raj Rajaratnam), Q3 2008 [View article]
Sequenom's Bombshell [View article]
Goldman Sachs Hedge Fund Trend Monitor [View article]
Goldman Sachs Hedge Fund Trend Monitor [View article]
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships [View article]
AMAG Pharmaceuticals' Feraheme: The Next Billion Dollar Drug [View article]
Wednesday's Options Recap [View article]
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships [View article]
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships [View article]
Expect FDA Approval of AMAG Pharmaceutical's Feraheme [View article]
FDA Calendar: 18 Hot Summer Trades [View article]
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart [View article]
Closing Update for Wednesday, July 1 [View article]
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart [View article]
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG [View article]